2026
New Tax Disclosure Regimes Still Leave Gaps in Information (1)
New corporate tax disclosures will provide investors with some answers to the persistent puzzle of where companies book their profits and pay their taxes—but some pieces of the puzzle are still going to be missing.
Pillar 2 and Related Benefits — The Case of the Swiss Canton of Zug
This article analyzes the development of post-pillar 2 business incentives in the Swiss canton of Zug, focusing on efforts to comply with GLOBE rules that prohibit related benefits and may jeopardize eligibility for a domestic minimum top-up tax. Wenz and Kaiser observe that Zug transitioned from income-based incentives to expenditure-based subsidies, although certain elements may continue to generate uncertainty during peer review. This case demonstrates the influence of pillar 2 on subnational tax competition and incentive strategies, especially in low-tax jurisdictions seeking to maintain competitiveness without risking disqualification under the OECD framework.
To read more, click here.
‘Definitely a Sham’: As Tariffs Climb, Trade Fraud and Accounting Tricks Proliferate
This article examines how rising tariffs on Chinese imports have led to widespread trade fraud and accounting manipulation, as firms attempt to circumvent higher duties. It highlights practices such as misclassification of goods and rerouting through third countries, raising significant enforcement challenges. These developments are directly relevant to international tax and trade compliance, as tariff avoidance strategies often intersect with transfer pricing and customs valuation issues. The piece underscores how increased trade barriers can distort reporting and complicate cross-border regulatory enforcement.
To read the full article, click here (subscription required).
OpenAI’s Altman releases blueprint for taxing, regulating artificial intelligence
OpenAI published a policy blueprint for artificial intelligence recommending a revised social contract to prepare for the technology’s likely impact on the economy, workforce and overall state of humans.
Can a Corporate Wealth Tax Happen?
Avi-Yonah argues that a corporate wealth tax is more feasible than an individual wealth tax, as it addresses the mobility and valuation challenges that hinder the direct taxation of wealthy individuals. Avi-Yonah further explains that this tax could be structured as a constitutionally valid excise on corporate operations, coordinated internationally through a pillar 2-style framework, and credited against the corporate income tax. This approach offers an alternative for taxing concentrated corporate wealth and prompts reconsideration of the relationship between wealth taxation and the existing corporate income tax.
To read more, click here.
Tariffs Return as Clock Ticks Down on Trump’s 10%: Supply Lines
The Trump administration is preparing to outline a tiered system for its broad tariffs on steel and aluminum products in an attempt to simplify a process that has dogged American companies for months.
Interest Deduction Tweak Prompts Thoughts of Offshore Borrowing
American companies with a big global footprint are reconsidering their debt strategies in the US after a change in Republicans’ 2025 tax law that limits their ability to deduct interest expenses.
Rival Nations Seize On Choke Points to Counter Trump
This article explores how countries are leveraging strategic economic “choke points” to counter U.S. trade policies, including restrictions on critical supply chains and financial flows. It highlights the growing use of economic tools as geopolitical leverage, with implications for global trade and cross-border investment. These developments are relevant to international tax because shifting supply chains and geopolitical fragmentation can affect where profits are earned and taxed. The piece provides useful context for understanding how global tax systems respond to increasingly politicized trade environments.
To read the full article, click here (subscription required).
Trump Administration Readies New Tariffs on Select Drugmakers
The Trump administration is set to announce tariffs on drugmakers that haven’t struck deals guaranteeing low prices in the US, according to people familiar with the plan, the latest move to tax imported goods on national security grounds.
Member Companies
